Ascendis Pharma A/S (ASND)
129.37
3.32 (2.63%)
At close: Jan 28, 2025, 3:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| PE Ratio | -13.32 | -10.97 | -16.89 | -16.49 | -26.46 | -17.25 | -9 | -7.45 | -12.14 | -27.28 | 36.25 | 123.31 | n/a |
| PS Ratio | 24.05 | 124.97 | 833.09 | 993.40 | 431.35 | 212.13 | 728.64 | 110.85 | 49.22 | 18.84 | 7.25 | 9.89 | n/a |
| PB Ratio | -44.02 | 24.28 | 7.33 | 8.24 | 9.66 | 8.01 | 5.95 | 2.89 | 3.32 | 5.75 | 23.47 | 99.06 | n/a |
| P/FCF Ratio | -13.65 | -12.54 | -14.66 | -23.57 | -31.86 | -15.87 | -11.61 | -8.39 | -8.98 | -14.01 | 28.91 | -163.45 | n/a |
| P/OCF Ratio | -13.72 | -12.9 | -15.51 | -25.44 | -32.79 | -16.17 | -11.72 | -8.48 | -9.19 | -14.32 | 23.43 | -236.41 | n/a |
| OCF/S Ratio | -1.75 | -9.69 | -53.7 | -39.05 | -13.15 | -13.12 | -62.16 | -13.07 | -5.35 | -1.32 | 0.31 | -0.04 | n/a |
| Debt / Equity Ratio | -4.42 | 1.93 | 0.12 | 0.11 | 0.06 | n/a | n/a | n/a | n/a | n/a | n/a | 0.14 | 1.72 |
| Quick Ratio | 2.50 | 4.63 | 7.28 | 14.02 | 12.74 | 7.53 | 8.61 | 13.67 | 10.98 | 4.13 | 1.04 | 0.87 | 0.80 |
| Current Ratio | 3.56 | 5.39 | 8.03 | 14.02 | 12.74 | 7.53 | 8.61 | 13.67 | 10.98 | 4.13 | 1.04 | 0.87 | 0.80 |
| Asset Turnover | 0.32 | 0.05 | 0.01 | 0.01 | 0.02 | 0.03 | 0.01 | 0.02 | 0.06 | 0.24 | 0.76 | 0.61 | n/a |
| Interest Coverage | -10.34 | -11.13 | -115.52 | -172.38 | -185.68 | -1.22K | -1.15K | -14.58K | -6.97K | -749.31 | 659.88 | 75.65 | n/a |
| Return on Equity (ROE) | 3.30 | -2.21 | -0.43 | -0.5 | -0.37 | -0.46 | -0.66 | -0.39 | -0.27 | -0.21 | 0.65 | 0.80 | n/a |
| Return on Assets (ROA) | -0.58 | -0.54 | -0.35 | -0.43 | -0.32 | -0.41 | -0.59 | -0.36 | -0.25 | -0.16 | 0.15 | 0.05 | n/a |
| Return on Capital (ROIC) | -0.73 | -0.61 | -0.46 | -0.36 | -0.36 | -0.55 | -0.6 | -0.41 | -0.35 | -0.26 | 0.84 | 0.97 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 83.36% | 76.28% | 54.71% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | n/a |
| Net Profit Margin | -180.51% | -1.14K% | -4.93K% | -6.03K% | -1.63K% | -1.23K% | -8.10K% | -1.49K% | -405.54% | -69.07% | 19.99% | 8.02% | n/a |
| Pretax Profit Margin | -177.77% | -1.13K% | -4.94K% | -6.03K% | -1.63K% | -1.23K% | -8.13K% | -1.49K% | -413.57% | -73.95% | 23.05% | 8.25% | n/a |
| Operating Profit Margin | -170.79% | -1.10K% | -5.81K% | -4.76K% | -1.70K% | -1.46K% | -7.29K% | -1.58K% | -515.21% | -85.74% | 25.87% | 9.71% | n/a |
| FCF Margin | -176.14% | -996.97% | -5.68K% | -4.22K% | -1.35K% | -1.34K% | -6.28K% | -1.32K% | -548.23% | -134.51% | 25.06% | -6.05% | n/a |
| EBITDA Margin | -154.16% | -1.09K% | -5.45K% | -4.73K% | -1.62K% | -1.42K% | -7.18K% | -1.57K% | -406.63% | -82.14% | 27.85% | 11.10% | n/a |